Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × Nivolumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 29 Carcinoma, Non-Small-Cell Lung 24 Carcinoma, Renal Cell 22 Neoplasm Metastasis 12 Stomach Neoplasms 11 Neoplasms 11 Lung Neoplasms 11 Carcinoma, Hepatocellular 10 Carcinoma, Transitional Cell 9 Adenocarcinoma Of Esophagus 9 Squamous Cell Carcinoma of Head and Neck 8 Urinary Bladder Neoplasms 7 Ovarian Neoplasms 7 Multiple Myeloma 7 Colorectal Neoplasms 7 Rectal Neoplasms 6 Prostatic Neoplasms 6 Thyroid Neoplasms 5 Esophageal Neoplasms 5 Brain Neoplasms 5 Uveal Melanoma 4 Urethral Neoplasms 4 Recurrence 4 Nasopharyngeal Carcinoma 4 Lymphoma 4 Colonic Neoplasms 4 Carcinoma, Basal Cell 4 Anus Neoplasms 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3

Interventions

Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 tazemetostat 1 etoposide phosphate 1 duvelisib 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Carmustine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡